AMICAS Wants Merge Offer Rebuffed

Medical imaging software vendor AMICAS Inc. is asking its stockholders to reject an unsolicited proposal from rival Merge Healthcare to buy the company for $6.05 per share.

Author
HDM Staff
Save
Share

    Medical imaging software vendor AMICAS Inc. is asking its stockholders to reject an unsolicited proposal from rival Merge Healthcare to buy the company for $6.05 per share.

    Boston-based AMICAS in December agreed to sell its business to investment firm Thoma Bravo LLC for $5.35 per share. "This purchase price is fully financed and guaranteed by Thoma Bravo and other first tier private equity funds and is not dependent on unguaranteed, third-party financing," AMICAS said in a Feb. 22 statement.

    In contrast, AMICAS calls Milwaukee-based Merge's offer a "highly-conditional proposal" that does not provide sufficient financial guarantees and reasonable protections for stockholders.

    In response, Merge Healthcare notes it has received a signed bridge financing commitment from Morgan Stanley to provide $200 million of debt financing. The company also has $40 million of pre-funded equity investments.

    More information is available at businesswire.com/news/home/20100222006352/en and
    http://amicas.mediaroom.com/index.php?s=43&item=176.

    --Joseph Goedert